Global Niraparib Market Growth 2023-2029

March 2023 | 77 pages | ID: G713CBF417CEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Niraparib Industry Forecast” looks at past sales and reviews total world Niraparib sales in 2022, providing a comprehensive analysis by region and market sector of projected Niraparib sales for 2023 through 2029. With Niraparib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Niraparib industry.

This Insight Report provides a comprehensive analysis of the global Niraparib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Niraparib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Niraparib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Niraparib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Niraparib.

The global Niraparib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Niraparib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Niraparib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Niraparib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Niraparib players cover TESARO and Everest Pharmaceuticals Limited etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Niraparib market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• 100mg*30 Capsules
• 100mg*60 Capsules
• 100mg*90 Capsules

Segmentation by application

• Recurrent Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Primary Peritoneal Cancer
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• TESARO
• Everest Pharmaceuticals Limited

Key Questions Addressed in this Report

What is the 10-year outlook for the global Niraparib market?

What factors are driving Niraparib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Niraparib market opportunities vary by end market size?

How does Niraparib break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Niraparib Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Niraparib by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Niraparib by Country/Region, 2018, 2022 & 2029
2.2 Niraparib Segment by Type
  2.2.1 100mg*30 Capsules
  2.2.2 100mg*60 Capsules
  2.2.3 100mg*90 Capsules
2.3 Niraparib Sales by Type
  2.3.1 Global Niraparib Sales Market Share by Type (2018-2023)
  2.3.2 Global Niraparib Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Niraparib Sale Price by Type (2018-2023)
2.4 Niraparib Segment by Application
  2.4.1 Recurrent Epithelial Ovarian Cancer
  2.4.2 Fallopian Tube Cancer
  2.4.3 Primary Peritoneal Cancer
  2.4.4 Other
2.5 Niraparib Sales by Application
  2.5.1 Global Niraparib Sale Market Share by Application (2018-2023)
  2.5.2 Global Niraparib Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Niraparib Sale Price by Application (2018-2023)

3 GLOBAL NIRAPARIB BY COMPANY

3.1 Global Niraparib Breakdown Data by Company
  3.1.1 Global Niraparib Annual Sales by Company (2018-2023)
  3.1.2 Global Niraparib Sales Market Share by Company (2018-2023)
3.2 Global Niraparib Annual Revenue by Company (2018-2023)
  3.2.1 Global Niraparib Revenue by Company (2018-2023)
  3.2.2 Global Niraparib Revenue Market Share by Company (2018-2023)
3.3 Global Niraparib Sale Price by Company
3.4 Key Manufacturers Niraparib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Niraparib Product Location Distribution
  3.4.2 Players Niraparib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR NIRAPARIB BY GEOGRAPHIC REGION

4.1 World Historic Niraparib Market Size by Geographic Region (2018-2023)
  4.1.1 Global Niraparib Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Niraparib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Niraparib Market Size by Country/Region (2018-2023)
  4.2.1 Global Niraparib Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Niraparib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Niraparib Sales Growth
4.4 APAC Niraparib Sales Growth
4.5 Europe Niraparib Sales Growth
4.6 Middle East & Africa Niraparib Sales Growth

5 AMERICAS

5.1 Americas Niraparib Sales by Country
  5.1.1 Americas Niraparib Sales by Country (2018-2023)
  5.1.2 Americas Niraparib Revenue by Country (2018-2023)
5.2 Americas Niraparib Sales by Type
5.3 Americas Niraparib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Niraparib Sales by Region
  6.1.1 APAC Niraparib Sales by Region (2018-2023)
  6.1.2 APAC Niraparib Revenue by Region (2018-2023)
6.2 APAC Niraparib Sales by Type
6.3 APAC Niraparib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Niraparib by Country
  7.1.1 Europe Niraparib Sales by Country (2018-2023)
  7.1.2 Europe Niraparib Revenue by Country (2018-2023)
7.2 Europe Niraparib Sales by Type
7.3 Europe Niraparib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Niraparib by Country
  8.1.1 Middle East & Africa Niraparib Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Niraparib Revenue by Country (2018-2023)
8.2 Middle East & Africa Niraparib Sales by Type
8.3 Middle East & Africa Niraparib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Niraparib
10.3 Manufacturing Process Analysis of Niraparib
10.4 Industry Chain Structure of Niraparib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Niraparib Distributors
11.3 Niraparib Customer

12 WORLD FORECAST REVIEW FOR NIRAPARIB BY GEOGRAPHIC REGION

12.1 Global Niraparib Market Size Forecast by Region
  12.1.1 Global Niraparib Forecast by Region (2024-2029)
  12.1.2 Global Niraparib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Niraparib Forecast by Type
12.7 Global Niraparib Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 TESARO
  13.1.1 TESARO Company Information
  13.1.2 TESARO Niraparib Product Portfolios and Specifications
  13.1.3 TESARO Niraparib Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 TESARO Main Business Overview
  13.1.5 TESARO Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Niraparib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Niraparib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 100mg*30 Capsules
Table 4. Major Players of 100mg*60 Capsules
Table 5. Major Players of 100mg*90 Capsules
Table 6. Global Niraparib Sales by Type (2018-2023) & (K Pcs)
Table 7. Global Niraparib Sales Market Share by Type (2018-2023)
Table 8. Global Niraparib Revenue by Type (2018-2023) & ($ million)
Table 9. Global Niraparib Revenue Market Share by Type (2018-2023)
Table 10. Global Niraparib Sale Price by Type (2018-2023) & (USD/Pcs)
Table 11. Global Niraparib Sales by Application (2018-2023) & (K Pcs)
Table 12. Global Niraparib Sales Market Share by Application (2018-2023)
Table 13. Global Niraparib Revenue by Application (2018-2023)
Table 14. Global Niraparib Revenue Market Share by Application (2018-2023)
Table 15. Global Niraparib Sale Price by Application (2018-2023) & (USD/Pcs)
Table 16. Global Niraparib Sales by Company (2018-2023) & (K Pcs)
Table 17. Global Niraparib Sales Market Share by Company (2018-2023)
Table 18. Global Niraparib Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Niraparib Revenue Market Share by Company (2018-2023)
Table 20. Global Niraparib Sale Price by Company (2018-2023) & (USD/Pcs)
Table 21. Key Manufacturers Niraparib Producing Area Distribution and Sales Area
Table 22. Players Niraparib Products Offered
Table 23. Niraparib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Niraparib Sales by Geographic Region (2018-2023) & (K Pcs)
Table 27. Global Niraparib Sales Market Share Geographic Region (2018-2023)
Table 28. Global Niraparib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Niraparib Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Niraparib Sales by Country/Region (2018-2023) & (K Pcs)
Table 31. Global Niraparib Sales Market Share by Country/Region (2018-2023)
Table 32. Global Niraparib Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Niraparib Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Niraparib Sales by Country (2018-2023) & (K Pcs)
Table 35. Americas Niraparib Sales Market Share by Country (2018-2023)
Table 36. Americas Niraparib Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Niraparib Revenue Market Share by Country (2018-2023)
Table 38. Americas Niraparib Sales by Type (2018-2023) & (K Pcs)
Table 39. Americas Niraparib Sales by Application (2018-2023) & (K Pcs)
Table 40. APAC Niraparib Sales by Region (2018-2023) & (K Pcs)
Table 41. APAC Niraparib Sales Market Share by Region (2018-2023)
Table 42. APAC Niraparib Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Niraparib Revenue Market Share by Region (2018-2023)
Table 44. APAC Niraparib Sales by Type (2018-2023) & (K Pcs)
Table 45. APAC Niraparib Sales by Application (2018-2023) & (K Pcs)
Table 46. Europe Niraparib Sales by Country (2018-2023) & (K Pcs)
Table 47. Europe Niraparib Sales Market Share by Country (2018-2023)
Table 48. Europe Niraparib Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Niraparib Revenue Market Share by Country (2018-2023)
Table 50. Europe Niraparib Sales by Type (2018-2023) & (K Pcs)
Table 51. Europe Niraparib Sales by Application (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Niraparib Sales by Country (2018-2023) & (K Pcs)
Table 53. Middle East & Africa Niraparib Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Niraparib Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Niraparib Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Niraparib Sales by Type (2018-2023) & (K Pcs)
Table 57. Middle East & Africa Niraparib Sales by Application (2018-2023) & (K Pcs)
Table 58. Key Market Drivers & Growth Opportunities of Niraparib
Table 59. Key Market Challenges & Risks of Niraparib
Table 60. Key Industry Trends of Niraparib
Table 61. Niraparib Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Niraparib Distributors List
Table 64. Niraparib Customer List
Table 65. Global Niraparib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 66. Global Niraparib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Niraparib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 68. Americas Niraparib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Niraparib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 70. APAC Niraparib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Niraparib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 72. Europe Niraparib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Niraparib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 74. Middle East & Africa Niraparib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Niraparib Sales Forecast by Type (2024-2029) & (K Pcs)
Table 76. Global Niraparib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Niraparib Sales Forecast by Application (2024-2029) & (K Pcs)
Table 78. Global Niraparib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. TESARO Basic Information, Niraparib Manufacturing Base, Sales Area and Its Competitors
Table 80. TESARO Niraparib Product Portfolios and Specifications
Table 81. TESARO Niraparib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 82. TESARO Main Business
Table 83. TESARO Latest Developments
Table 84. Everest Pharmaceuticals Limited Basic Information, Niraparib Manufacturing Base, Sales Area and Its Competitors
Table 85. Everest Pharmaceuticals Limited Niraparib Product Portfolios and Specifications
Table 86. Everest Pharmaceuticals Limited Niraparib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 87. Everest Pharmaceuticals Limited Main Business
Table 88. Everest Pharmaceuticals Limited Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Niraparib
Figure 2. Niraparib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Niraparib Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Niraparib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Niraparib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 100mg*30 Capsules
Figure 10. Product Picture of 100mg*60 Capsules
Figure 11. Product Picture of 100mg*90 Capsules
Figure 12. Global Niraparib Sales Market Share by Type in 2022
Figure 13. Global Niraparib Revenue Market Share by Type (2018-2023)
Figure 14. Niraparib Consumed in Recurrent Epithelial Ovarian Cancer
Figure 15. Global Niraparib Market: Recurrent Epithelial Ovarian Cancer (2018-2023) & (K Pcs)
Figure 16. Niraparib Consumed in Fallopian Tube Cancer
Figure 17. Global Niraparib Market: Fallopian Tube Cancer (2018-2023) & (K Pcs)
Figure 18. Niraparib Consumed in Primary Peritoneal Cancer
Figure 19. Global Niraparib Market: Primary Peritoneal Cancer (2018-2023) & (K Pcs)
Figure 20. Niraparib Consumed in Other
Figure 21. Global Niraparib Market: Other (2018-2023) & (K Pcs)
Figure 22. Global Niraparib Sales Market Share by Application (2022)
Figure 23. Global Niraparib Revenue Market Share by Application in 2022
Figure 24. Niraparib Sales Market by Company in 2022 (K Pcs)
Figure 25. Global Niraparib Sales Market Share by Company in 2022
Figure 26. Niraparib Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Niraparib Revenue Market Share by Company in 2022
Figure 28. Global Niraparib Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Niraparib Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Niraparib Sales 2018-2023 (K Pcs)
Figure 31. Americas Niraparib Revenue 2018-2023 ($ Millions)
Figure 32. APAC Niraparib Sales 2018-2023 (K Pcs)
Figure 33. APAC Niraparib Revenue 2018-2023 ($ Millions)
Figure 34. Europe Niraparib Sales 2018-2023 (K Pcs)
Figure 35. Europe Niraparib Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Niraparib Sales 2018-2023 (K Pcs)
Figure 37. Middle East & Africa Niraparib Revenue 2018-2023 ($ Millions)
Figure 38. Americas Niraparib Sales Market Share by Country in 2022
Figure 39. Americas Niraparib Revenue Market Share by Country in 2022
Figure 40. Americas Niraparib Sales Market Share by Type (2018-2023)
Figure 41. Americas Niraparib Sales Market Share by Application (2018-2023)
Figure 42. United States Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Niraparib Sales Market Share by Region in 2022
Figure 47. APAC Niraparib Revenue Market Share by Regions in 2022
Figure 48. APAC Niraparib Sales Market Share by Type (2018-2023)
Figure 49. APAC Niraparib Sales Market Share by Application (2018-2023)
Figure 50. China Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Niraparib Sales Market Share by Country in 2022
Figure 58. Europe Niraparib Revenue Market Share by Country in 2022
Figure 59. Europe Niraparib Sales Market Share by Type (2018-2023)
Figure 60. Europe Niraparib Sales Market Share by Application (2018-2023)
Figure 61. Germany Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Niraparib Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Niraparib Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Niraparib Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Niraparib Sales Market Share by Application (2018-2023)
Figure 70. Egypt Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Niraparib Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Niraparib in 2022
Figure 76. Manufacturing Process Analysis of Niraparib
Figure 77. Industry Chain Structure of Niraparib
Figure 78. Channels of Distribution
Figure 79. Global Niraparib Sales Market Forecast by Region (2024-2029)
Figure 80. Global Niraparib Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Niraparib Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Niraparib Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Niraparib Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Niraparib Revenue Market Share Forecast by Application (2024-2029)